1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsZeroing In: Ending the HIV Epidemic program is sponsored by Gilead Sciences. This program provides grants to help reduce health disparities, improve access to quality healthcare, advance medical education, and support local communities most impacted by the HIV epidemic and COVID-19 pandemic.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Zeroing In: Ending the HIV Epidemic Zeroing In: Ending the HIV Epidemic Zeroing In ® : Ending the HIV Epidemic Grant Program We believe that all people should have access to quality healthcare. Through the Zeroing In: Ending the HIV Epidemic (EHE) grant program, we aim to support organizations working to increase the overall health and wellness of communities most impacted by HIV around the world.
Organizations supported to help end the HIV epidemic Countries in which grantee organizations operate We recognize the vital role community-based and grassroots organizations play in delivering high-quality, supportive HIV prevention and care services to key populations. Through Zeroing In, we support organizations with programs that align with established international and country-specific EHE goals.
Relevant programs include local community programming, multi-organization community-driven projects and coalition-led proposals from organizations collaborating to end the epidemic. Projects prioritize key populations as described in local EHE plans and centered on one or more of our three focus areas.
Digital Health Innovations Many Zeroing In program efforts emphasize innovative ideas for creating or improving a nonprofit's technology infrastructure or developing digital outreach strategies to reach key populations. Community Outreach and Education Innovative community outreach projects have the potential to reach populations that require greater health support through engagement, education and empowerment.
Comprehensive HIV Innovation Programs Efforts supported through the Zeroing In program include, but are not limited to: Innovative non-clinical testing programs Supportive service programs Comprehensive HIV prevention programs inclusive of biomedical prevention options Through the Zeroing In program, we've awarded $24 million in grants to help reduce health disparities, improve access to quality healthcare, advance medical education and support local communities most impacted by the HIV epidemic.
Zeroing In also provided support for those impacted during the height of the COVID-19 pandemic. Zeroing In: Latin America Region The Zeroing In Latin America Region project supports organizations working to increase the overall health and wellness of populations that have been most impacted by HIV in Latin America.
We've supported projects that prioritize populations most affected by HIV that provide: Innovative comprehensive HIV programs Culturally and socially-affirming support services Community outreach and education Explore Other Initiatives Gilead Compass Initiative®
According to the current listing, eligibility includes: Organizations working to address the HIV epidemic and COVID-19 pandemic in under-resourced communities. Confirm the full requirements in the official notice before applying.
Zeroing In: Ending the HIV Epidemic program is funded by Gilead Sciences. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The U.S. Government Policy for Stopping High-Risk Life Sciences Research, released July 28, 2026 under EO 14292 and implemented at NIH through NOT-OD-26-101, replaces mitigation with prohibition. It bans dangerous gain-of-function research outright, gates potential DGOF behind government-wide review, and creates International Research of Concern — a research-security regime wearing biosafety clothing. Penalties run to five-year debarment and False Claims Act exposure.
Read articleSchmidt Sciences opened a 'Scaling AI Safety for a Multi-Agent World' program with awards up to $1 million and an August 8, 2026 deadline. Against a backdrop of federal research slowdowns, here is why private science philanthropy matters more than ever, how these funders differ from federal agencies, and how researchers should approach them.
Read articleNSF's Arctic Research Opportunities solicitation funds roughly 75 awards a year — up to $50 million — across six program areas from natural sciences to social sciences to the Arctic Observing Network. The July 15, 2026 target date is not a hard deadline, and understanding that distinction is the first strategic decision an Arctic researcher makes. Here is how the six doors differ and how to choose the right one.
Read article